From Nasdaq: 2024-05-03 18:15:03

Intellia Therapeutics, Inc. (NTLA) experienced a 1.42% increase in stock price, reaching $23.60 amid a positive trading day. The company’s upcoming earnings report on May 9, 2024, is expected to show a decline in earnings per share by 15.38%. Analyst estimates project revenue growth of 23.74% for the quarter and 40.49% for the year.

In the Medical – Biomedical and Genetics industry, Intellia Therapeutics, Inc. falls within the top 28% of over 250 industries with a Zacks Industry Rank of 69. Industry rankings affect stock performance, with the top-rated industries outperforming the lower-rated industries at a 2 to 1 ratio. Investors can benefit from tracking these metrics on Zacks.com.

Bitcoin has proven to be the highest returning asset class, outperforming other investments consistently. In recent presidential election years, Bitcoin saw significant returns: +272.4% (2012), +161.1% (2016), and +302.8% (2020). Analysts predict another surge in Bitcoin’s value in the coming months, making it a lucrative investment opportunity.



Read more at Nasdaq: Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today